You are now leaving our website. Kindly note that this link is offered as a service and EVER is not responsible for any content published on the thirds-party website you are about to enter.
Imprint The www.cerebrolysin.com site is offered to you by: EVER Neuro Pharma GmbH Oberburgau 3 4866 Unterach, Austria Phone: +43 7665 20555 0 Fax:+43 7665 20555 910 …
Welcome to Cerebrolysin Cerebrolysin is a multi-modal neuropeptide drug which improves the brain's ability for self-repair by stimulating neurorecovery. Cerebrolysin is used for…
Congresses11th World Congress for NeuroRehabilitation https://www.wcnr-congress.org/ Date: 7th to 10th October 2020 Location: Lyon, France33rd Annual Congress of the European Society of…
Clinical efficacy and patient benefits Several clinical pilot trials have been performed using Cerebrolysin in traumatic brain injury. Cerebrolysin was administered as an adjunctive…
Expert InterviewsInterview with Chief Investigator of Captain We asked the CAPTAIN key investigator Prof. Dafin Muresanu for an interview and discussed with him some topics like dosage regime of…
Privacy and Cookie PolicyInformation to be provided pursuant to Article 13 of the EU General Data Protection Regulation (GDPR) When you access our websites, access data (date, time, page viewed,…
Download area - Stroke This page includes some information that is intended for registered useres only. If you would like to access this information please login.> General Cerebrolysin…
About Cerebrolysin Cerebrolysin is a multi-modal neuropeptide drug with a fast onset of action that helps to regain and maintain the independence of patients suffering from stroke, TBI, dementia and…
